---
$id: https://graph.org.ai/products/commodity/51263122
$type: Product
source: UNSPSC
code: "51263122"
title: "Esmolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Esmolol

**UNSPSC Code**: 51263122
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H25NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MDY902UXSR, chemically known as benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester but generally known as esmolol, which bears US NIH Compound Identifier 59768. European Medicines Agency schedules Esmolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13718MIG. The term ESMOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules esmolol in its Anatomical Therapeutic Chemical (ATC) Classification. ESMOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule esmolol under HS 29221980 and SITC 51461. As of Q4 2014, ESMOLOL remains the US FDA Preferred Term for this commodity. Esmolol bears US NLM identifiers UMLS ID C0116569 and NCI Concept Code C72617. SMILES: O(CC(O)CNC(C)C)C1CCC(CCC(=O)OC)CC1.

